BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: American Diabetes Association. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2018. Diabetes Care. 2018;41 (Suppl 1):S55-S64. [PMID: 29222377 DOI: 10.2337/dc18-s006] [Cited by in Crossref: 472] [Cited by in F6Publishing: 216] [Article Influence: 118.0] [Reference Citation Analysis]
Number Citing Articles
1 Abdullah MFILB, Sidi H, Ravindran A, Gosse PJ, Kaunismaa ES, Mainland RL, Mustafa N, Hatta NH, Arnawati P, Zulkifli AY, Woon LS. How Much Do We Know about the Biopsychosocial Predictors of Glycaemic Control? Age and Clinical Factors Predict Glycaemic Control, but Psychological Factors Do Not. J Diabetes Res 2020;2020:2654208. [PMID: 32455131 DOI: 10.1155/2020/2654208] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Hirsch IB, Miller E. Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives. Diabetes Technol Ther 2021;23:S72-80. [PMID: 34546085 DOI: 10.1089/dia.2021.0233] [Reference Citation Analysis]
3 Omar SM, Musa IR, ElSouli A, Adam I. Prevalence, risk factors, and glycaemic control of type 2 diabetes mellitus in eastern Sudan: a community-based study. Ther Adv Endocrinol Metab 2019;10:2042018819860071. [PMID: 31275546 DOI: 10.1177/2042018819860071] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wahabi H. Prevalence and Risk Factors for Glucose Intolerance among Saudi Women with Gestational Diabetes. J Diabetes Res 2018;2018:4282347. [PMID: 30186874 DOI: 10.1155/2018/4282347] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
5 Karlsson SA, Franzén S, Svensson AM, Miftaraj M, Eliasson B, Andersson Sundell K. Prescription of lipid-lowering medications for patients with type 2 diabetes mellitus and risk-associated LDL cholesterol: a nationwide study of guideline adherence from the Swedish National Diabetes Register. BMC Health Serv Res 2018;18:900. [PMID: 30486824 DOI: 10.1186/s12913-018-3707-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
6 Gabrielsen J, Girone G, Bennett B, Jung A. Long-Acting Somatostatin Analogue Safety Monitoring Protocol for Outpatients With Neuroendocrine Tumors. J Adv Pract Oncol 2019;10:646-59. [PMID: 33391850 DOI: 10.6004/jadpro.2019.10.7.2] [Reference Citation Analysis]
7 Heller S, Lingvay I, Marso SP, Philis-Tsimikas A, Pieber TR, Poulter NR, Pratley RE, Hachmann-Nielsen E, Kvist K, Lange M, Moses AC, Trock Andresen M, Buse JB; DEVOTE Study Group. Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE. Diabetes Obes Metab 2020;22:2248-56. [PMID: 32996693 DOI: 10.1111/dom.14208] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Milman T, Joundi RA, Alotaibi NM, Saposnik G. Clinical inertia in the pharmacological management of hypertension: A systematic review and meta-analysis. Medicine (Baltimore) 2018;97:e11121. [PMID: 29924011 DOI: 10.1097/MD.0000000000011121] [Cited by in Crossref: 31] [Cited by in F6Publishing: 19] [Article Influence: 7.8] [Reference Citation Analysis]
9 Rhee MK, Ho YL, Raghavan S, Vassy JL, Cho K, Gagnon D, Staimez LR, Ford CN, Wilson PWF, Phillips LS. Random plasma glucose predicts the diagnosis of diabetes. PLoS One 2019;14:e0219964. [PMID: 31323063 DOI: 10.1371/journal.pone.0219964] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
10 Addala A, Igudesman D, Kahkoska AR, Muntis FR, Souris KJ, Whitaker KJ, Pratley RE, Mayer-Davis E. The interplay of type 1 diabetes and weight management: A qualitative study exploring thematic progression from adolescence to young adulthood. Pediatr Diabetes 2019;20:974-85. [PMID: 31392807 DOI: 10.1111/pedi.12903] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
11 Patti AM, Giglio RV, Pafili K, Rizzo M, Papanas N. Advances in pharmacological treatment of type 1 diabetes during pregnancy. Expert Opin Pharmacother 2019;20:983-9. [PMID: 30924387 DOI: 10.1080/14656566.2019.1593372] [Reference Citation Analysis]
12 McCarthy MM, Whittemore R, Gholson G, Grey M. Diabetes Distress, Depressive Symptoms, and Cardiovascular Health in Adults With Type 1 Diabetes. Nurs Res 2019;68:445-52. [PMID: 31693550 DOI: 10.1097/NNR.0000000000000387] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Sheikh K, Bartz SK, Lyons SK, DeSalvo DJ. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study. J Diabetes Res 2018;2018:5162162. [PMID: 30151393 DOI: 10.1155/2018/5162162] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Braune K, Gajewska KA, Thieffry A, Lewis DM, Froment T, O'Donnell S, Speight J, Hendrieckx C, Schipp J, Skinner T, Langstrup H, Tappe A, Raile K, Cleal B. Why #WeAreNotWaiting-Motivations and Self-Reported Outcomes Among Users of Open-source Automated Insulin Delivery Systems: Multinational Survey. J Med Internet Res 2021;23:e25409. [PMID: 34096874 DOI: 10.2196/25409] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Hirsch IB, Sherr JL, Hood KK. Connecting the Dots: Validation of Time in Range Metrics With Microvascular Outcomes. Diabetes Care 2019;42:345-8. [PMID: 30787056 DOI: 10.2337/dci18-0040] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 6.7] [Reference Citation Analysis]
16 Naseri S, Brewster RCL, Blumenthal PD. Novel use of menstrual blood for monitoring glycaemic control in patients with diabetes: a proof-of-concept study. BMJ Sex Reprod Health 2021:bmjsrh-2021-201211. [PMID: 34759003 DOI: 10.1136/bmjsrh-2021-201211] [Reference Citation Analysis]
17 Lee B, Heo YJ, Lee YA, Lee J, Kim JH, Lee SY, Shin CH, Yang SW. Association between hemoglobin glycation index and cardiometabolic risk factors in Korean pediatric nondiabetic population. Ann Pediatr Endocrinol Metab 2018;23:196-203. [PMID: 30599480 DOI: 10.6065/apem.2018.23.4.196] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
18 Satirapoj B, Pratipanawatr T, Ongphiphadhanakul B, Suwanwalaikorn S, Benjasuratwong Y, Nitiyanant W. Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand. BMJ Open 2020;10:e031612. [PMID: 32051301 DOI: 10.1136/bmjopen-2019-031612] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Papademetriou V, Alataki S, Stavropoulos K, Papadopoulos C, Bakogiannis K, Tsioufis K. Pharmacological Management of Diabetic Nephropathy. Curr Vasc Pharmacol 2020;18:139-47. [PMID: 30961500 DOI: 10.2174/1570161117666190405164749] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
20 Aronow WS, Shamliyan TA. Blood pressure targets for hypertension in patients with type 2 diabetes. Ann Transl Med 2018;6:199. [PMID: 30023362 DOI: 10.21037/atm.2018.04.36] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
21 Silva AM, Nunes CL, Matias CN, Jesus F, Francisco R, Cardoso M, Santos I, Carraça EV, Silva MN, Sardinha LB, Martins P, Minderico CS. Champ4life Study Protocol: A One-Year Randomized Controlled Trial of a Lifestyle Intervention for Inactive Former Elite Athletes with Overweight/Obesity. Nutrients 2020;12:E286. [PMID: 31973208 DOI: 10.3390/nu12020286] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
22 Hirsch IB, Wright EE Jr. Using Flash Continuous Glucose Monitoring in Primary Practice. Clin Diabetes 2019;37:150-61. [PMID: 31057221 DOI: 10.2337/cd18-0054] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
23 Lee J, Callaghan T, Ory M, Zhao H, Bolin JN. The Impact of Medicaid Expansion on Diabetes Management. Diabetes Care 2020;43:1094-101. [PMID: 31649097 DOI: 10.2337/dc19-1173] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 de Marañón AM, Iannantuoni F, Abad-Jiménez Z, Canet F, Díaz-Pozo P, López-Domènech S, Roldán-Torres I, Morillas C, Rocha M, Víctor VM. Association between Proinflammatory Markers, Leukocyte-Endothelium Interactions, and Carotid Intima-Media Thickness in Type 2 Diabetes: Role of Glycemic Control. J Clin Med 2020;9:E2522. [PMID: 32764458 DOI: 10.3390/jcm9082522] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Lin CS, Lee YT, Fang WH, Lou YS, Kuo FC, Lee CC, Lin C. Deep Learning Algorithm for Management of Diabetes Mellitus via Electrocardiogram-Based Glycated Hemoglobin (ECG-HbA1c): A Retrospective Cohort Study. J Pers Med 2021;11:725. [PMID: 34442369 DOI: 10.3390/jpm11080725] [Reference Citation Analysis]
26 Alhodaib HI, Alsulihem S. Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia. World J Diabetes 2021; 12(11): 1908-1916 [PMID: 34888015 DOI: 10.4239/wjd.v12.i11.1908] [Reference Citation Analysis]
27 Jiang L, Wang S, Zhao J, Huang W, Li J, Xiao Y, Zhang H, Fu Q, Chen Y, Yang T, Shen EA, Su G, Zhang Y, Li Z. Qingre Yiqi Method along with Oral Hypoglycemic Drugs in Treating Adults with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2021;2021:4395228. [PMID: 34552649 DOI: 10.1155/2021/4395228] [Reference Citation Analysis]
28 Wang S, Ji X, Zhang Z, Xue F. Relationship between Lipid Profiles and Glycemic Control Among Patients with Type 2 Diabetes in Qingdao, China. Int J Environ Res Public Health 2020;17:E5317. [PMID: 32718055 DOI: 10.3390/ijerph17155317] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
29 Silbert R, Salcido-Montenegro A, Rodriguez-Gutierrez R, Katabi A, McCoy RG. Hypoglycemia Among Patients with Type 2 Diabetes: Epidemiology, Risk Factors, and Prevention Strategies. Curr Diab Rep. 2018;18:53. [PMID: 29931579 DOI: 10.1007/s11892-018-1018-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 9.5] [Reference Citation Analysis]
30 Doose M, Steinberg MB, Xing CY, Lin Y, Cantor JC, Hong CC, Demissie K, Bandera EV, Tsui J. Comorbidity Management in Black Women Diagnosed with Breast Cancer: the Role of Primary Care in Shared Care. J Gen Intern Med 2021;36:138-46. [PMID: 32974725 DOI: 10.1007/s11606-020-06234-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, Wolfsdorf JI, Schatz D. Type 1 Diabetes in Children and Adolescents: A Position Statement by the American Diabetes Association. Diabetes Care. 2018;41:2026-2044. [PMID: 30093549 DOI: 10.2337/dci18-0023] [Cited by in Crossref: 113] [Cited by in F6Publishing: 91] [Article Influence: 28.3] [Reference Citation Analysis]
32 Tran PMH, Kim E, Tran LKH, Khaled BS, Hopkins D, Gardiner M, Bryant J, Bernard R, Morgan J, Bode B, Reed JC, She JX, Purohit S. T1DMicro: A Clinical Risk Calculator for Type 1 Diabetes Related Microvascular Complications. Int J Environ Res Public Health 2021;18:11094. [PMID: 34769614 DOI: 10.3390/ijerph182111094] [Reference Citation Analysis]
33 Pöhlmann J, Mitchell BD, Bajpai S, Osumili B, Valentine WJ. Nasal Glucagon Versus Injectable Glucagon for Severe Hypoglycemia: A Cost-Offset and Budget Impact Analysis. J Diabetes Sci Technol 2019;13:910-8. [PMID: 30700165 DOI: 10.1177/1932296819826577] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
34 Roberts AJ, Malik F, Pihoker C, Dickerson JA. Adapting to telemedicine in the COVID-19 era: Feasibility of dried blood spot testing for hemoglobin A1c. Diabetes Metab Syndr 2021;15:433-7. [PMID: 33588200 DOI: 10.1016/j.dsx.2021.02.010] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Jin, Huang WJ, Meng X, Yang F, Bao Q, Zhang MZ, Yang YN, Ni Q, Lian FM, Tong XL. Chinese herbal medicine Tangshen Formula treatment for type 2 diabetic kidney disease in the early stage: study protocol for a randomized controlled trial. Trials 2019;20:756. [PMID: 31864393 DOI: 10.1186/s13063-019-3821-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
36 Sokolov V, Yakovleva T, Ueda S, Parkinson J, Boulton DW, Penland RC, Tang W. Urinary glucose excretion after dapagliflozin treatment: An exposure-response modelling comparison between Japanese and non-Japanese patients diagnosed with type 1 diabetes mellitus. Diabetes Obes Metab 2019;21:829-36. [PMID: 30456904 DOI: 10.1111/dom.13586] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kumar A, Schwarz D, Acharya B, Agrawal P, Aryal A, Choudhury N, Citrin D, Dangal B, Deukmedjian G, Dhimal M, Dhungana S, Gauchan B, Gupta T, Halliday S, Jha D, Kalaunee SP, Karmacharya B, Kishore S, Koirala B, Kunwar L, Mahar R, Maru S, Mehanni S, Nirola I, Pandey S, Pant B, Pathak M, Poudel S, Rajbhandari I, Raut A, Rimal P, Schwarz R, Shrestha A, Thapa A, Thapa P, Thapa R, Wong L, Maru D. Designing and implementing an integrated non-communicable disease primary care intervention in rural Nepal. BMJ Glob Health 2019;4:e001343. [PMID: 31139453 DOI: 10.1136/bmjgh-2018-001343] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
38 Blonde L, Brunton SA, Chava P, Zhou R, Meyers J, Davis KL, Dalal MR, DiGenio A. Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice. Diabetes Spectr 2019;32:93-103. [PMID: 31168279 DOI: 10.2337/ds17-0082] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
39 Darraj H, Badedi M, Poore KR, Hummadi A, Khawaji A, Solan Y, Zakri I, Sabai A, Darraj M, Mutawwam DA, Daghreeri M, Sayed S, Alaallah W, Alfadhly A, Alsabaani A. Vitamin D deficiency and glycemic control among patients with type 2 diabetes mellitus in Jazan City, Saudi Arabia. Diabetes Metab Syndr Obes 2019;12:853-62. [PMID: 31239741 DOI: 10.2147/DMSO.S203700] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 4.7] [Reference Citation Analysis]
40 Patel N, Verchinina L, Wichorek M, Gardner TW, Markel D, Wyckoff J, Shah AR. Identification of population characteristics through implementation of the Comprehensive Diabetic Retinopathy Program. Clin Diabetes Endocrinol 2019;5:6. [PMID: 31086678 DOI: 10.1186/s40842-019-0079-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Zhang J, Gelman IH, Katsuta E, Liang Y, Wang X, Li J, Qu J, Yan L, Takabe K, Hochwald SN. Glucose Drives Growth Factor-Independent Esophageal Cancer Proliferation via Phosphohistidine-Focal Adhesion Kinase Signaling. Cell Mol Gastroenterol Hepatol 2019;8:37-60. [PMID: 30836148 DOI: 10.1016/j.jcmgh.2019.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
42 Nair P, Kee KW, Mah CS, Lee ES. Evaluating the Impact of Outpatient Multi-Dose Medication Packaging Service (MDMPS) on Medication Adherence and Clinical Outcomes. J Prim Care Community Health 2020;11:2150132720965085. [PMID: 33089747 DOI: 10.1177/2150132720965085] [Reference Citation Analysis]
43 Núñez M, Díaz S, Dilla T, Reviriego J, Pérez A. Epidemiology, Quality of Life, and Costs Associated with Hypoglycemia in Patients with Diabetes in Spain: A Systematic Literature Review. Diabetes Ther 2019;10:375-92. [PMID: 30661221 DOI: 10.1007/s13300-019-0563-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Alves Peres H, Leira Pereira LR, Zangiacomine Martinez E, Viana CM, de Freitas MCF. Elucidating factors associated with non-adherence among Type 1 diabetes patients in primary care setting in Southeastern Brazil. Prim Care Diabetes 2020;14:85-92. [PMID: 31262602 DOI: 10.1016/j.pcd.2019.06.002] [Reference Citation Analysis]
45 RJ, Beck RW, Scioscia MF, Umpierrez GE, Tuttle KR. Glycemic Monitoring and management in advanced chronic kidney disease. Endocr Rev. 2020;41:756-774. [PMID: 32455432 DOI: 10.1210/endrev/bnaa017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
46 Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia. 2018;61:2461-2498. [PMID: 30288571 DOI: 10.1007/s00125-018-4729-5] [Cited by in Crossref: 562] [Cited by in F6Publishing: 447] [Article Influence: 187.3] [Reference Citation Analysis]
47 Fritzen K, Basinska K, Rubio-Almanza M, Nicolucci A, Kennon B, Vergès B, Zakrzewska K, Schnell O. Pan-European Economic Analysis to Identify Cost Savings for the Health Care Systems as a Result of Integrating Glucose Monitoring Based Telemedical Approaches Into Diabetes Management. J Diabetes Sci Technol 2019;13:1112-22. [PMID: 30917691 DOI: 10.1177/1932296819835172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
48 Reiterer F, Freckmann G. Advanced carbohydrate counting: An engineering perspective. Annual Reviews in Control 2019;48:401-22. [DOI: 10.1016/j.arcontrol.2019.06.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
49 Alssema M, Ruijgrok C, Blaak EE, Egli L, Dussort P, Vinoy S, Dekker JM, Denise Robertson M. Effects of alpha-glucosidase-inhibiting drugs on acute postprandial glucose and insulin responses: a systematic review and meta-analysis. Nutr Diabetes 2021;11:11. [PMID: 33658478 DOI: 10.1038/s41387-021-00152-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
50 Lechleitner M, Clodi M, Abrahamian H, Brath H, Brix J, Drexel H, Fasching P, Föger B, Francesconi C, Fröhlich-Reiterer E, Harreiter J, Hofer SE, Hoppichler F, Huber J, Kaser S, Kautzky-Willer A, Ludvik B, Luger A, Mader JK, Paulweber B, Pieber T, Prager R, Rami-Merhar B, Resl M, Riedl M, Roden M, Saely CH, Schelkshorn C, Schernthaner G, Sourij H, Stechemesser L, Stingl H, Toplak H, Wascher TC, Weitgasser R, Winhofer-Stöckl Y, Zlamal-Fortunat S. [Insulin therapy of type 2 diabetes mellitus (Update 2019)]. Wien Klin Wochenschr 2019;131:39-46. [PMID: 30980147 DOI: 10.1007/s00508-019-1492-7] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Magee MF, Baker KM, Fernandez SJ, Huang CC, Mete M, Montero AR, Nassar CM, Sack PA, Smith K, Youssef GA, Evans SR. Redesigning ambulatory care management for uncontrolled type 2 diabetes: a prospective cohort study of the impact of a Boot Camp model on outcomes. BMJ Open Diabetes Res Care 2019;7:e000731. [PMID: 31798894 DOI: 10.1136/bmjdrc-2019-000731] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
52 Ito Y, Ambe K, Hayase T, Kobayashi M, Tohkin M. Comparison of Efficacy of Dipeptidyl Peptidase-4 Inhibitors and Sodium-Glucose Co-Transporter 2 Inhibitors Between Japanese and Non-Japanese Patients: A Meta-Analysis. Clin Transl Sci 2020;13:498-508. [PMID: 31880866 DOI: 10.1111/cts.12732] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
53 Nørgaard CH, Mosslemi M, Lee CJ, Torp-Pedersen C, Wong ND. The Importance and Role of Multiple Risk Factor Control in Type 2 Diabetes. Curr Cardiol Rep 2019;21:35. [PMID: 30887139 DOI: 10.1007/s11886-019-1123-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
54 Park GM, Lee CH, Lee SW, Yun SC, Kim YH, Kim YG, Won KB, Ann SH, Kim SJ, Yang DH, Kang JW, Lim TH, Koh EH, Lee WJ, Kim MS, Park JY, Kim HK, Choe J, Lee SG. Impact of Diabetes Control on Subclinical Atherosclerosis: Analysis from Coronary Computed Tomographic Angiography Registry. Diabetes Metab J 2020;44:470-9. [PMID: 31769239 DOI: 10.4093/dmj.2019.0073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
55 Wong JC, Izadi Z, Schroeder S, Nader M, Min J, Neinstein AB, Adi S. A Pilot Study of Use of a Software Platform for the Collection, Integration, and Visualization of Diabetes Device Data by Health Care Providers in a Multidisciplinary Pediatric Setting. Diabetes Technol Ther 2018;20:806-16. [PMID: 30461307 DOI: 10.1089/dia.2018.0251] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 3.3] [Reference Citation Analysis]
56 Landau Z, Kowen-Sandbank G, Jakubowicz D, Raziel A, Sakran N, Zaslavsky-Paltiel I, Lerner-Geva L, Pinhas-Hamiel O. Bariatric surgery in patients with type 1 diabetes: special considerations are warranted. Ther Adv Endocrinol Metab 2019;10:2042018818822207. [PMID: 30728940 DOI: 10.1177/2042018818822207] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
57 Campbell JA, Yan A, Egede LE. Community-Based Participatory Research Interventions to Improve Diabetes Outcomes: A Systematic Review. Diabetes Educ 2020;46:527-39. [PMID: 33353510 DOI: 10.1177/0145721720962969] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
58 Tarigan TJE, Dwijayanti A, Setyowati S, Louisa M. Immunogenicity and Efficacy of Insulin Glargine Biosimilar Ezelin versus Originator Insulin Glargine in Patients with Type 2 Diabetes. Diabetes Metab Syndr Obes 2021;14:107-16. [PMID: 33469328 DOI: 10.2147/DMSO.S279385] [Reference Citation Analysis]
59 Seo W, Lee YB, Lee S, Jin SM, Park SM. A machine-learning approach to predict postprandial hypoglycemia. BMC Med Inform Decis Mak 2019;19:210. [PMID: 31694629 DOI: 10.1186/s12911-019-0943-4] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 5.7] [Reference Citation Analysis]
60 Saenz-Pipaon G, Echeverria S, Orbe J, Roncal C. Urinary Extracellular Vesicles for Diabetic Kidney Disease Diagnosis. J Clin Med 2021;10:2046. [PMID: 34064661 DOI: 10.3390/jcm10102046] [Reference Citation Analysis]
61 Meldgaard T, Keller J, Olesen AE, Olesen SS, Krogh K, Borre M, Farmer A, Brock B, Brock C, Drewes AM. Pathophysiology and management of diabetic gastroenteropathy. Therap Adv Gastroenterol. 2019;12:1756284819852047. [PMID: 31244895 DOI: 10.1177/1756284819852047] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
62 Tien KJ, Hung YJ, Chen JF, Chen CC, Wang CY, Hwu CM, Huang YY, Hsiao PJ, Tu ST, Wang CH, Sheu WH. Basal insulin therapy: Unmet medical needs in Asia and the new insulin glargine in diabetes treatment. J Diabetes Investig 2019;10:560-70. [PMID: 30520564 DOI: 10.1111/jdi.12984] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
63 Kim KS. Self-Monitoring of Blood Glucose in Patients with Insulin-Treated Type 2 Diabetes Mellitus. Diabetes Metab J 2018;42:26-7. [PMID: 29504304 DOI: 10.4093/dmj.2018.42.1.26] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Osei E, Zandbergen A, Brouwers PJAM, Mulder LJMM, Koudstaal P, Lingsma H, Dippel DWJ, den Hertog H. Safety, feasibility and efficacy of metformin and sitagliptin in patients with a TIA or minor ischaemic stroke and impaired glucose tolerance. BMJ Open 2021;11:e046113. [PMID: 34531203 DOI: 10.1136/bmjopen-2020-046113] [Reference Citation Analysis]
65 Letta S, Aga F, Yadeta TA, Geda B, Dessie Y. Barriers to Diabetes Patients' Self-Care Practices in Eastern Ethiopia: A Qualitative Study from the Health Care Providers Perspective. Diabetes Metab Syndr Obes 2021;14:4335-49. [PMID: 34712054 DOI: 10.2147/DMSO.S335731] [Reference Citation Analysis]
66 Karlsson SA, Eliasson B, Franzén S, Miftaraj M, Svensson AM, Andersson Sundell K. Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden. BMJ Open Diabetes Res Care 2019;7:e000639. [PMID: 31114701 DOI: 10.1136/bmjdrc-2018-000639] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
67 Ahmad I, Zelnick LR, Batacchi Z, Robinson N, Dighe A, Manski-Nankervis JE, Furler J, O'Neal DN, Little R, Trence D, Hirsch IB, Bansal N, de Boer IH. Hypoglycemia in People with Type 2 Diabetes and CKD. Clin J Am Soc Nephrol 2019;14:844-53. [PMID: 30996047 DOI: 10.2215/CJN.11650918] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
68 Nakanishi S, Hirukawa H, Shimoda M, Tatsumi F, Kohara K, Obata A, Kimura T, Okauchi S, Kinoshita T, Sanada J, Fushimi Y, Nishioka M, Mizoguchi A, Mune T, Kaku K, Kaneto H. Verification of Kumamoto Declaration 2013 and Glycemic Targets for Elderly Patients with Diabetes in Japan for prevention of diabetic complications: A retrospective longitudinal study using outpatient clinical data. J Diabetes Investig 2019;10:290-301. [PMID: 30099853 DOI: 10.1111/jdi.12909] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
69 Niznik JD, Hunnicutt JN, Zhao X, Mor MK, Sileanu F, Aspinall SL, Springer SP, Ersek MJ, Gellad WF, Schleiden LJ, Hanlon JT, Thorpe JM, Thorpe CT. Deintensification of Diabetes Medications among Veterans at the End of Life in VA Nursing Homes. J Am Geriatr Soc 2020;68:736-45. [PMID: 32065387 DOI: 10.1111/jgs.16360] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
70 Akpınar K, Aslan D, Fenkçi SM. Assessment of estimated glomerular filtration rate based on cystatin C in diabetic nephropathy. J Bras Nefrol 2021;43:340-8. [PMID: 33599678 DOI: 10.1590/2175-8239-JBN-2020-0145] [Reference Citation Analysis]
71 Evans M, Ceriello A, Danne T, De Block C, DeVries JH, Lind M, Mathieu C, Nørgaard K, Renard E, Wilmot EG. Use of fast-acting insulin aspart in insulin pump therapy in clinical practice. Diabetes Obes Metab 2019;21:2039-47. [PMID: 31144428 DOI: 10.1111/dom.13798] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
72 Zhang Y, Liu C, Luo S, Huang J, Li X, Zhou Z. Effectiveness of Lilly Connected Care Program (LCCP) App-Based Diabetes Education for Patients With Type 2 Diabetes Treated With Insulin: Retrospective Real-World Study. JMIR Mhealth Uhealth 2020;8:e17455. [PMID: 32141838 DOI: 10.2196/17455] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
73 Tosun B, Cinar FI, Topcu Z, Masatoglu B, Ozen N, Bagcivan G, Kilic O, Demirci C, Altunbas A, Sonmez A. Do patients with diabetes use the insulin pen properly? Afr Health Sci 2019;19:1628-37. [PMID: 31148992 DOI: 10.4314/ahs.v19i1.38] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
74 Torbjørnsen A, Ribu L, Rønnevig M, Grøttland A, Helseth S. Users' acceptability of a mobile application for persons with type 2 diabetes: a qualitative study. BMC Health Serv Res 2019;19:641. [PMID: 31492176 DOI: 10.1186/s12913-019-4486-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 9.3] [Reference Citation Analysis]
75 Magny-Normilus C, Mawn B, Dalton J. Self-Management of Type 2 Diabetes in Adult Haitian Immigrants: A Qualitative Study. J Transcult Nurs 2020;31:51-8. [PMID: 30957666 DOI: 10.1177/1043659619841586] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
76 Kaczmarski J, Jankowska-śliwińska J, Borysiewicz MA. IGZO MESFET with enzyme-modified Schottky gate electrode for glucose sensing. Jpn J Appl Phys 2019;58:090603. [DOI: 10.7567/1347-4065/ab1a65] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Chen F, Xu S, Wang Y, Chen F, Cao L, Liu T, Huang T, Wei Q, Ma G, Zhao Y, Wang D. Risk Factors for Sarcopenia in the Elderly with Type 2 Diabetes Mellitus and the Effect of Metformin. J Diabetes Res 2020;2020:3950404. [PMID: 33083494 DOI: 10.1155/2020/3950404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
78 Jin JL, Cao YX, Wu LG, You XD, Guo N, Guo YL, Wu NQ, Zhu CG, Xu RX, Liu HH, Sun J, Dong Q, Gao Y, Li JJ. Atherogenic dyslipidaemia and cardiovascular events in patients with diabetes or pre-diabetes and stable coronary artery disease: a prospective, cohort study. BMJ Open 2021;11:e037340. [PMID: 33455923 DOI: 10.1136/bmjopen-2020-037340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 Dagdelen S, Deyneli O, Dinccag N, Ilkova H, Osar Siva Z, Yetkin I, Yilmaz T. Expert Panel Recommendations for Use of Standardized Glucose Reporting System Based on Standardized Glucometrics Plus Visual Ambulatory Glucose Profile (AGP) Data in Clinical Practice. Front Endocrinol 2022;12:663222. [DOI: 10.3389/fendo.2021.663222] [Reference Citation Analysis]
80 Harris S, Abrahamson MJ, Ceriello A, Charpentier G, Evans M, Lehmann R, Liebl A, Linjawi S, Holt RIG, Hosszúfalusi N, Rutten G, Vilsbøll T. Clinical Considerations When Initiating and Titrating Insulin Degludec/Liraglutide (IDegLira) in People with Type 2 Diabetes. Drugs 2020;80:147-65. [PMID: 31960258 DOI: 10.1007/s40265-019-01245-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
81 Wang X, Wang F, Wu H, Chen X, Xie R, Chen T, Sun H, Zhang D, Chen L. Detection and analysis of glucose metabolism-related genes in childhood diabetes using targeted next-generation sequencing: In pediatric population-a hospital-based study. Exp Ther Med 2020;19:3398-404. [PMID: 32266039 DOI: 10.3892/etm.2020.8579] [Reference Citation Analysis]
82 Buse JB, Carlson AL, Komatsu M, Mosenzon O, Rose L, Liang B, Buchholtz K, Horio H, Kadowaki T. Fast-acting insulin aspart versus insulin aspart in the setting of insulin degludec-treated type 1 diabetes: Efficacy and safety from a randomized double-blind trial. Diabetes Obes Metab 2018;20:2885-93. [PMID: 30259644 DOI: 10.1111/dom.13545] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 6.8] [Reference Citation Analysis]
83 DiMeglio LA, Evans-Molina C, Oram RA. Type 1 diabetes. Lancet. 2018;391:2449-2462. [PMID: 29916386 DOI: 10.1016/s0140-6736(18)31320-5] [Cited by in Crossref: 227] [Cited by in F6Publishing: 130] [Article Influence: 56.8] [Reference Citation Analysis]
84 Murphree DH, Arabmakki E, Ngufor C, Storlie CB, McCoy RG. Stacked classifiers for individualized prediction of glycemic control following initiation of metformin therapy in type 2 diabetes. Comput Biol Med 2018;103:109-15. [PMID: 30347342 DOI: 10.1016/j.compbiomed.2018.10.017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
85 Alvarez PM, Young LA, Mitchell M, Blakeney TG, Buse JB, Vu MB, Weaver MA, Rees J, Grimm K, Donahue KE. Health Literacy, Glycemic Control, and Physician-Advised Glucose Self-Monitoring Use in Type 2 Diabetes. Diabetes Spectr 2018;31:344-7. [PMID: 30510390 DOI: 10.2337/ds18-0064] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
86 O'Carroll-Lolait A, Urwin A, Doughty I, Schofield J, Thabit H, Leelarathna L. Trends in HbA1c and other biochemical outcomes of individuals with newly diagnosed type 1 diabetes. Ir J Med Sci 2021;190:999-1004. [PMID: 33231831 DOI: 10.1007/s11845-020-02434-w] [Reference Citation Analysis]
87 Genovese MC, Burmester GR, Hagino O, Thangavelu K, Iglesias-Rodriguez M, John GS, González-Gay MA, Mandrup-Poulsen T, Fleischmann R. Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials. Arthritis Res Ther 2020;22:206. [PMID: 32907617 DOI: 10.1186/s13075-020-02229-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Kang ZQ, Huo JL, Zhai XJ. Effects of perioperative tight glycemic control on postoperative outcomes: a meta-analysis. Endocr Connect 2018;7:R316-27. [PMID: 30120204 DOI: 10.1530/EC-18-0231] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
89 Aldawi N, Darwiche G, Abusnana S, Elbagir M, Elgzyri T. Initial increase in glucose variability during Ramadan fasting in non-insulin-treated patients with diabetes type 2 using continuous glucose monitoring. Libyan J Med 2019;14:1535747. [PMID: 30348064 DOI: 10.1080/19932820.2018.1535747] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
90 O'Donnell S, Lewis D, Marchante Fernández M, Wäldchen M, Cleal B, Skinner T, Raile K, Tappe A, Ubben T, Willaing I, Hauck B, Wolf S, Braune K. Evidence on User-Led Innovation in Diabetes Technology (The OPEN Project): Protocol for a Mixed Methods Study. JMIR Res Protoc 2019;8:e15368. [PMID: 31742563 DOI: 10.2196/15368] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
91 Haneda M, Kadowaki T, Ito H, Sasaki K, Hiraide S, Ishii M, Matsukawa M, Ueno M. Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance. Diabetes Ther 2018;9:1083-97. [PMID: 29637459 DOI: 10.1007/s13300-018-0416-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
92 Lim S, Ku EJ, Lee SY, Lee JH, Lee JE, Kim KM, Davies MJ. Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study. BMJ Open Diabetes Res Care 2020;8:e000807. [PMID: 31958303 DOI: 10.1136/bmjdrc-2019-000807] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Dong Z, Gao X, Chinchilli VM, Sinha R, Muscat J, Winkels RM, Richie JP Jr. Association of sulfur amino acid consumption with cardiometabolic risk factors: Cross-sectional findings from NHANES III. EClinicalMedicine 2020;19:100248. [PMID: 32140669 DOI: 10.1016/j.eclinm.2019.100248] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 6.5] [Reference Citation Analysis]
94 Chow LS, Manoogian ENC, Alvear A, Fleischer JG, Thor H, Dietsche K, Wang Q, Hodges JS, Esch N, Malaeb S, Harindhanavudhi T, Nair KS, Panda S, Mashek DG. Time-Restricted Eating Effects on Body Composition and Metabolic Measures in Humans who are Overweight: A Feasibility Study. Obesity (Silver Spring) 2020;28:860-9. [PMID: 32270927 DOI: 10.1002/oby.22756] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 23.5] [Reference Citation Analysis]
95 Joshi A, Mitra A, Anjum N, Shrivastava N, Khadanga S, Pakhare A, Joshi R. Patterns of Glycemic Variability During a Diabetes Self-Management Educational Program. Med Sci (Basel) 2019;7:E52. [PMID: 30934620 DOI: 10.3390/medsci7030052] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
96 Hirsch IB, Nardacci E, Verderese CA. Flash Continuous Glucose Monitoring: Implications for Use of Continuous Data in Daily Diabetes Management. Diabetes Spectr 2019;32:355-67. [PMID: 31798294 DOI: 10.2337/ds18-0059] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
97 Eerdekens GJ, Rex S, Mesotten D. Accuracy of Blood Glucose Measurement and Blood Glucose Targets. J Diabetes Sci Technol 2020;14:553-9. [PMID: 32046520 DOI: 10.1177/1932296820905581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
98 Kotfis K, Szylińska A, Listewnik M, Brykczyński M, Ely EW, Rotter I. Diabetes and elevated preoperative HbA1c level as risk factors for postoperative delirium after cardiac surgery: an observational cohort study. Neuropsychiatr Dis Treat 2019;15:511-21. [PMID: 30863073 DOI: 10.2147/NDT.S196973] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 3.7] [Reference Citation Analysis]
99 Ren Q, Ji LN, Lu JM, Li YF, Li QM, Lin SS, Lv XF, Wang L, Xu Y, Guo XH, Guo QY, Ma L, Du J, Chen YL, Zhao CL, Zhang QL, She QM, Jiao XM, Lu MH, Sun XM, Gao Y, Zhang J. Search for clinical predictors of good glycemic control in patients starting or intensifying oral hypoglycemic pharmacological therapy: A multicenter prospective cohort study. J Diabetes Complications 2020;34:107464. [PMID: 31771933 DOI: 10.1016/j.jdiacomp.2019.107464] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
100 Schneiders J, Telo GH, Bottino LG, Pasinato B, Neyeloff JL, Schaan BD. Quality indicators in type 2 diabetes patient care: analysis per care-complexity level. Diabetol Metab Syndr 2019;11:34. [PMID: 31073334 DOI: 10.1186/s13098-019-0428-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
101 Nusca A, Tuccinardi D, Proscia C, Melfi R, Manfrini S, Nicolucci A, Ceriello A, Pozzilli P, Ussia GP, Grigioni F, Di Sciascio G. Incremental role of glycaemic variability over HbA1c in identifying type 2 diabetic patients with high platelet reactivity undergoing percutaneous coronary intervention. Cardiovasc Diabetol 2019;18:147. [PMID: 31706305 DOI: 10.1186/s12933-019-0952-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
102 Li Y, Li X, Zhang Y, Zhang L, Wu Q, Bai Z, Si J, Zuo X, Shi N, Li J, Chu X. Impact of glycemic control status on patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention. BMC Cardiovasc Disord 2020;20:36. [PMID: 32000678 DOI: 10.1186/s12872-020-01339-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
103 Mao L, Lu J, Zhang Q, Zhao Y, Chen G, Sun M, Chang F, Li X. Family-based intervention for patients with type 2 diabetes via WeChat in China: protocol for a randomized controlled trial. BMC Public Health 2019;19:381. [PMID: 30953483 DOI: 10.1186/s12889-019-6702-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
104 Hirst JA, Farmer AJ, Smith MC, Stevens RJ. Timings for HbA1c testing in people with diabetes are associated with incentive payments: an analysis of UK primary care data. Diabet Med 2019;36:36-43. [PMID: 30175871 DOI: 10.1111/dme.13810] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
105 Wilmot EG, Choudhary P, Leelarathna L, Baxter M. Glycaemic variability: The under-recognized therapeutic target in type 1 diabetes care. Diabetes Obes Metab 2019;21:2599-608. [PMID: 31364268 DOI: 10.1111/dom.13842] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
106 Davidson JA, Desouza C, Fonseca V, Frias JP, Van Gaal L, Giorgino F, Chao J, Dex TA, Roberts M, Saremi A, Leiter LA. Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials. Diabet Med 2020;37:256-66. [PMID: 31365765 DOI: 10.1111/dme.14094] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
107 Yang W, Ma J, Yuan G, Li L, Zhang M, Lu Y, Ye X, Song W, Liu M, Wu J, Chen R, Li Y, Zhang X, Cui N, Yang J. Determining the optimal fasting glucose target for patients with type 2 diabetes: Results of the multicentre, open-label, randomized-controlled FPG GOAL trial. Diabetes Obes Metab 2019;21:1973-7. [PMID: 30938035 DOI: 10.1111/dom.13733] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
108 Sosa-Rubí SG, Contreras-Loya D, Pedraza-Arizmendi D, Chivardi-Moreno C, Alarid-Escudero F, López-Ridaura R, Servan-Mori E, Molina-Cuevas V, Casales-Hernández G, Espinosa-López C, González-Roldán JF, Silva-Tinoco R, Seiglie J, Gómez-Dantés O. Cost-effectiveness analysis of a multidisciplinary health-care model for patients with type-2 diabetes implemented in the public sector in Mexico: A quasi-experimental, retrospective evaluation. Diabetes Res Clin Pract 2020;167:108336. [PMID: 32755762 DOI: 10.1016/j.diabres.2020.108336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
109 Rickels MR. Hypoglycemia-associated autonomic failure, counterregulatory responses, and therapeutic options in type 1 diabetes. Ann N Y Acad Sci 2019;1454:68-79. [PMID: 31389033 DOI: 10.1111/nyas.14214] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
110 Bertachi A, Biagi L, Beneyto A, Vehí J. Dynamic Rule-Based Algorithm to Tune Insulin-on-Board Constraints for a Hybrid Artificial Pancreas System. J Healthc Eng 2020;2020:1414597. [PMID: 32399164 DOI: 10.1155/2020/1414597] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
111 Yang Y, Peng N, Chen G, Wan Q, Yan L, Wang G, Qin Y, Luo Z, Tang X, Huo Y, Hu R, Ye Z, Qin G, Gao Z, Su Q, Mu Y, Zhao J, Chen L, Zeng T, Yu X, Li Q, Shen F, Chen L, Zhang Y, Wang Y, Deng H, Liu C, Wu S, Yang T, Li M, Xu Y, Xu M, Zhao Z, Wang T, Lu J, Bi Y, Wang W, Ning G, Zhang Q, Shi L. Interaction between smoking and diabetes in relation to subsequent risk of cardiovascular events. Cardiovasc Diabetol 2022;21. [DOI: 10.1186/s12933-022-01447-2] [Reference Citation Analysis]
112 Mahoney GK, Henk HJ, McCoy RG. Severe Hypoglycemia Attributable to Intensive Glucose-Lowering Therapy Among US Adults With Diabetes: Population-Based Modeling Study, 2011-2014. Mayo Clin Proc 2019;94:1731-42. [PMID: 31422897 DOI: 10.1016/j.mayocp.2019.02.028] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
113 Zhang Y, Li X, Luo S, Liu C, Liu F, Zhou Z. Exploration of Users' Perspectives and Needs and Design of a Type 1 Diabetes Management Mobile App: Mixed-Methods Study. JMIR Mhealth Uhealth 2018;6:e11400. [PMID: 30249580 DOI: 10.2196/11400] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
114 Brandão-Lima PN, Carvalho GB, Santos RKF, Santos BDC, Dias-Vasconcelos NL, Rocha VS, Barbosa KBF, Pires LV. Intakes of Zinc, Potassium, Calcium, and Magnesium of Individuals with Type 2 Diabetes Mellitus and the Relationship with Glycemic Control. Nutrients 2018;10:E1948. [PMID: 30544774 DOI: 10.3390/nu10121948] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
115 Mooradian AD. Evidence-Based Management of Diabetes in Older Adults. Drugs Aging 2018;35:1065-78. [PMID: 30306360 DOI: 10.1007/s40266-018-0598-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
116 Lind M, Pivodic A, Svensson AM, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ 2019;366:l4894. [PMID: 31462492 DOI: 10.1136/bmj.l4894] [Cited by in Crossref: 34] [Cited by in F6Publishing: 24] [Article Influence: 11.3] [Reference Citation Analysis]
117 DeFronzo RA, Abdul-Ghani M. Sodium-Glucose Cotransporter 2 Inhibitors and the Kidney. Diabetes Spectr 2021;34:225-34. [PMID: 34511848 DOI: 10.2337/ds20-0071] [Reference Citation Analysis]
118 Kwan CK, Fu SC, Yung PS. A high glucose level stimulate inflammation and weaken pro-resolving response in tendon cells - A possible factor contributing to tendinopathy in diabetic patients. Asia Pac J Sports Med Arthrosc Rehabil Technol. 2020;19:1-6. [PMID: 31871896 DOI: 10.1016/j.asmart.2019.10.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
119 Cho L, Davis M, Elgendy I, Epps K, Lindley KJ, Mehta PK, Michos ED, Minissian M, Pepine C, Vaccarino V, Volgman AS; ACC CVD Womens Committee Members. Summary of Updated Recommendations for Primary Prevention of Cardiovascular Disease in Women: JACC State-of-the-Art Review. J Am Coll Cardiol 2020;75:2602-18. [PMID: 32439010 DOI: 10.1016/j.jacc.2020.03.060] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 25.0] [Reference Citation Analysis]
120 Lee YS, Min KH, Lee SY, Shim JJ, Kang KH, Cho WH, Jeon D, Kim YS. The value of glycated hemoglobin as predictor of organ dysfunction in patients with sepsis. PLoS One 2019;14:e0216397. [PMID: 31059556 DOI: 10.1371/journal.pone.0216397] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
121 Greenberg JA, Zwiep TM, Sadek J, Malcolm JC, Mullen KA, McIsaac DI, Musselman RP, Moloo H. Clinical practice guideline: evidence, recommendations and algorithm for the preoperative optimization of anemia, hyperglycemia and smoking. Can J Surg 2021;64:E491-509. [PMID: 34598927 DOI: 10.1503/cjs.011519] [Reference Citation Analysis]
122 Gourdy P, Bahloul A, Boultif Z, Gouet D, Guerci B. Efficacy and Safety of Switching Patients Inadequately Controlled on Basal Insulin to Insulin Glargine 300 U/mL: The TRANSITION 2 Study. Diabetes Ther 2020;11:147-59. [PMID: 31782050 DOI: 10.1007/s13300-019-00734-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
123 Dorsey-Treviño EG, González-González JG, Alvarez-Villalobos N, González-Nava V, Contreras-Garza BM, Díaz González-Colmenero A, Rodríguez-Tamez G, Barrera-Flores FJ, Farrell AM, Montori VM, Rodriguez-Gutierrez R. Sodium-glucose cotransporter 2 (SGLT-2) inhibitors and microvascular outcomes in patients with type 2 diabetes: systematic review and meta-analysis. J Endocrinol Invest 2020;43:289-304. [PMID: 31489568 DOI: 10.1007/s40618-019-01103-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
124 Choi SE, Berkowitz SA, Yudkin JS, Naci H, Basu S. Personalizing Second-Line Type 2 Diabetes Treatment Selection: Combining Network Meta-analysis, Individualized Risk, and Patient Preferences for Unified Decision Support. Med Decis Making 2019;39:239-52. [PMID: 30767632 DOI: 10.1177/0272989X19829735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
125 Musso G, Gambino R, Cassader M, Paschetta E. Efficacy and safety of dual SGLT 1/2 inhibitor sotagliflozin in type 1 diabetes: meta-analysis of randomised controlled trials. BMJ 2019;365:l1328. [PMID: 30967375 DOI: 10.1136/bmj.l1328] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 12.3] [Reference Citation Analysis]
126 Adolfsson P, Parkin CG, Thomas A, Krinelke LG. Selecting the Appropriate Continuous Glucose Monitoring System - a Practical Approach. Eur Endocrinol 2018;14:24-9. [PMID: 29922348 DOI: 10.17925/EE.2018.14.1.24] [Cited by in Crossref: 25] [Cited by in F6Publishing: 10] [Article Influence: 6.3] [Reference Citation Analysis]
127 Chowdhury TA. Post-transplant diabetes mellitus. Clin Med (Lond) 2019;19:392-5. [PMID: 31530687 DOI: 10.7861/clinmed.2019-0195] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
128 Chehregosha H, Khamseh ME, Malek M, Hosseinpanah F, Ismail-Beigi F. A View Beyond HbA1c: Role of Continuous Glucose Monitoring. Diabetes Ther 2019;10:853-63. [PMID: 31037553 DOI: 10.1007/s13300-019-0619-1] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]
129 Alawadi F, Abdelgadir E, Bashier A, Hassanein M, Rashid F, Alsaeed M, Hafidh K, Elsayed MA, Abuelkheir S, Farooqi MH. Glycemic Control in Patients with Diabetes across Primary and Tertiary Government Health Sectors in the Emirate of Dubai, United Arab Emirates: A Five-Year Pattern. Oman Med J 2019;34:20-5. [PMID: 30671180 DOI: 10.5001/omj.2019.04] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
130 Ipingbemi AE, Erhun WO, Adisa R. Pharmacist-led intervention in treatment non-adherence and associated direct costs of management among ambulatory patients with type 2 diabetes in southwestern Nigeria. BMC Health Serv Res 2021;21:1000. [PMID: 34551779 DOI: 10.1186/s12913-021-06979-z] [Reference Citation Analysis]
131 Shen Z, Jiang H, Huang R, Zhou Y, Li Q, Ma J. Association of glycemic variability and hypoglycemia with distal symmetrical polyneuropathy in adults with type 1 diabetes. Sci Rep 2021;11:22875. [PMID: 34819569 DOI: 10.1038/s41598-021-02258-3] [Reference Citation Analysis]
132 Leung E, Wongrakpanich S, Munshi MN. Diabetes Management in the Elderly. Diabetes Spectr 2018;31:245-53. [PMID: 30140140 DOI: 10.2337/ds18-0033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
133 Aleppo G, Webb K. Continuous Glucose Monitoring Integration in Clinical Practice: A Stepped Guide to Data Review and Interpretation. J Diabetes Sci Technol 2019;13:664-73. [PMID: 30453772 DOI: 10.1177/1932296818813581] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
134 Murphy KA, Greer RC, Roter DL, Crews DC, Ephraim PL, Carson KA, Cooper LA, Albert MC, Boulware LE. Awareness and Discussions About Chronic Kidney Disease Among African-Americans with Chronic Kidney Disease and Hypertension: a Mixed Methods Study. J Gen Intern Med 2020;35:298-306. [PMID: 31720962 DOI: 10.1007/s11606-019-05540-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
135 Kudva YC, Ahmann AJ, Bergenstal RM, Gavin JR 3rd, Kruger DF, Midyett LK, Miller E, Harris DR. Approach to Using Trend Arrows in the FreeStyle Libre Flash Glucose Monitoring Systems in Adults. J Endocr Soc 2018;2:1320-37. [PMID: 30474069 DOI: 10.1210/js.2018-00294] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 9.8] [Reference Citation Analysis]
136 Dunseath GJ, Bright D, Luzio SD. Comparative Accuracy Evaluation of a Blood Glucose Meter With Novel Hematocrit Correction Technology, With Three Currently Used Commercially Available Blood Glucose Monitoring Systems. J Diabetes Sci Technol 2019;13:568-74. [PMID: 30623673 DOI: 10.1177/1932296818821389] [Reference Citation Analysis]
137 Cuadros DF, Li J, Musuka G, Awad SF. Spatial epidemiology of diabetes: Methods and insights. World J Diabetes 2021; 12(7): 1042-1056 [PMID: 34326953 DOI: 10.4239/wjd.v12.i7.1042] [Reference Citation Analysis]
138 Nishimura A, Harashima SI, Hosoda K, Arai H, Inagaki N. Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study. Ther Adv Endocrinol Metab 2019;10:2042018819833304. [PMID: 30858966 DOI: 10.1177/2042018819833304] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
139 Wang L, Li X, Wang Z, Bancks MP, Carnethon MR, Greenland P, Feng YQ, Wang H, Zhong VW. Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018. JAMA 2021. [PMID: 34170288 DOI: 10.1001/jama.2021.9883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
140 Manski-Nankervis JA, Thuraisingam S, Sluggett JK, Kilov G, Furler J, O'Neal D, Jenkins A. Prescribing of diabetes medications to people with type 2 diabetes and chronic kidney disease: a national cross-sectional study. BMC Fam Pract 2019;20:29. [PMID: 30777033 DOI: 10.1186/s12875-019-0915-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
141 Gardea J, Papadatos J, Cadle R. Evaluating glycemic control for patient-aligned care team clinical pharmacy specialists at a large Veterans Affairs medical center. Pharm Pract (Granada) 2018;16:1164. [PMID: 30023024 DOI: 10.18549/PharmPract.2018.02.1164] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
142 Parsons SN, Luzio SD, Harvey JN, Bain SC, Cheung WY, Watkins A, Owens DR. Effect of structured self-monitoring of blood glucose, with and without additional TeleCare support, on overall glycaemic control in non-insulin treated Type 2 diabetes: the SMBG Study, a 12-month randomized controlled trial. Diabet Med 2019;36:578-90. [PMID: 30653704 DOI: 10.1111/dme.13899] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
143 Atif M, Saleem Q, Asghar S, Malik I, Ahmad N. Extent and Predictors of Poor Glycaemic Control among Elderly Pakistani Patients with Type 2 Diabetes Mellitus: A Multi-Centre Cross-Sectional Study. Medicina (Kaunas) 2019;55:E21. [PMID: 30658518 DOI: 10.3390/medicina55010021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
144 Amsberg S, Wijk I, Livheim F, Toft E, Johansson UB, Anderbro T. Acceptance and commitment therapy (ACT) for adult type 1 diabetes management: study protocol for a randomised controlled trial. BMJ Open 2018;8:e022234. [PMID: 30498037 DOI: 10.1136/bmjopen-2018-022234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
145 Corbett JP, Breton MD, Patek SD. A Multiple Hypothesis Approach to Estimating Meal Times in Individuals With Type 1 Diabetes. J Diabetes Sci Technol 2021;15:141-6. [PMID: 31640408 DOI: 10.1177/1932296819883267] [Reference Citation Analysis]
146 Rodriguez-Gutierrez R, Mancillas-Adame LG, Rodríguez-Tamez G, Diaz Gonzalez-Colmenero A, Solis-Pacheco RC, Elizondo-Plazas AS, Santos-Santillana KM, Gonzalez-Sariñana L, Gonzalez-Nava V, Gonzalez-Gonzalez JG. Hypertriglyceridemia and Its Association with HbA1c Test: A Prospective In Vivo Controlled Study. Int J Endocrinol 2019;2019:4784313. [PMID: 30891069 DOI: 10.1155/2019/4784313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
147 Shen Y, Shi L, Nauman E, Katzmarzyk P, Price-Haywood E, Bazzano A, Nigam S, Hu G. Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes. J Stroke 2020;22:87-98. [PMID: 32027794 DOI: 10.5853/jos.2019.01704] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
148 Tomah S, Mahmoud N, Mottalib A, Pober DM, Tasabehji MW, Ashrafzadeh S, Hamdy O. Frequency of self-monitoring of blood glucose in relation to weight loss and A1C during intensive multidisciplinary weight management in patients with type 2 diabetes and obesity. BMJ Open Diabetes Res Care 2019;7:e000659. [PMID: 31413841 DOI: 10.1136/bmjdrc-2019-000659] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
149 Nyiraty S, Pesei F, Orosz A, Coluzzi S, Vági OE, Lengyel C, Ábrahám G, Frontoni S, Kempler P, Várkonyi T. Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association? Front Endocrinol (Lausanne) 2018;9:174. [PMID: 29725320 DOI: 10.3389/fendo.2018.00174] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
150 Sasso FC, Rinaldi L, Lascar N, Marrone A, Pafundi PC, Adinolfi LE, Marfella R. Role of Tight Glycemic Control during Acute Coronary Syndrome on CV Outcome in Type 2 Diabetes. J Diabetes Res 2018;2018:3106056. [PMID: 30402502 DOI: 10.1155/2018/3106056] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 7.0] [Reference Citation Analysis]
151 Hubbard RA, Lett E, Ho GYF, Chubak J. Characterizing Bias Due to Differential Exposure Ascertainment in Electronic Health Record Data. Health Serv Outcomes Res Methodol 2021;21:309-23. [PMID: 34366704 DOI: 10.1007/s10742-020-00235-3] [Reference Citation Analysis]
152 Gregorini M, Sepe V, Pattonieri FE, Allesina A, Rampino T. Early onset of graft glomerulopathy in a patient with post-transplant diabetes mellitus after renal transplantation: a case report. BMC Nephrol 2018;19:348. [PMID: 30526503 DOI: 10.1186/s12882-018-1141-9] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
153 Rao M, van Pelt M, LoGerfo J, Steinman LE, Heang H, Fitzpatrick AL. Utilization of diabetes management health care services and its association with glycemic control among patients participating in a peer educator-based program in Cambodia. PLoS One 2020;15:e0235037. [PMID: 32584854 DOI: 10.1371/journal.pone.0235037] [Reference Citation Analysis]
154 Sivitz WI, Phillips LS, Wexler DJ, Fortmann SP, Camp AW, Tiktin M, Perez M, Craig J, Hollander PA, Cherrington A, Aroda VR, Tan MH, Krakoff J, Rasouli N, Butera NM, Younes N; GRADE Research Group. Optimization of Metformin in the GRADE Cohort: Effect on Glycemia and Body Weight. Diabetes Care 2020;43:940-7. [PMID: 32139384 DOI: 10.2337/dc19-1769] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
155 Edeghere S, English P. Management of type 2 diabetes: now and the future. Clin Med (Lond) 2019;19:403-5. [PMID: 31530690 DOI: 10.7861/clinmed.2019-0318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Schwarz D, Dhungana S, Kumar A, Acharya B, Agrawal P, Aryal A, Baum A, Choudhury N, Citrin D, Dangal B, Dhimal M, Gauchan B, Gupta T, Halliday S, Karmacharya B, Kishore S, Koirala B, Kshatriya U, Levine E, Maru S, Rimal P, Sapkota S, Schwarz R, Shrestha A, Thapa A, Maru D. An integrated intervention for chronic care management in rural Nepal: protocol of a type 2 hybrid effectiveness-implementation study. Trials 2020;21:119. [PMID: 31996250 DOI: 10.1186/s13063-020-4063-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
157 Martin C, Perez-Molinar D, Shah M, Billington C. U500 Disposable Patch Insulin Pump: Results and Discussion of a Veterans Affairs Pilot Study. J Endocr Soc 2018;2:1275-83. [PMID: 30402591 DOI: 10.1210/js.2018-00198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
158 Deng H, Lin S, Yang X, Lv J, Luo S, Zeng L, Weng J, Xu W; CONFIDENCE Group. Effect of baseline body mass index on glycemic control and weight change with exenatide monotherapy in Chinese drug-naïve type 2 diabetic patients. J Diabetes 2019;11:509-18. [PMID: 30520243 DOI: 10.1111/1753-0407.12883] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
159 Niwaha AJ, Rodgers LR, Greiner R, Balungi PA, Mwebaze R, McDonald TJ, Hattersley AT, Shields BM, Nyirenda MJ, Jones AG. HbA1c performs well in monitoring glucose control even in populations with high prevalence of medical conditions that may alter its reliability: the OPTIMAL observational multicenter study. BMJ Open Diabetes Res Care 2021;9:e002350. [PMID: 34535465 DOI: 10.1136/bmjdrc-2021-002350] [Reference Citation Analysis]
160 Sheikh K, Bartz SK, Lyons SK, DeSalvo DJ. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study. J Diabetes Res 2018;2018:5162162. [PMID: 30151393 DOI: 10.1155/2018/5162162] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
161 Robinson SA, Netherton D, Zocchi M, Purington C, Ash AS, Shimada SL. Differences in Secure Messaging, Self-management, and Glycemic Control Between Rural and Urban Patients: Secondary Data Analysis. JMIR Diabetes 2021;6:e32320. [PMID: 34807834 DOI: 10.2196/32320] [Reference Citation Analysis]
162 Gomez-Peralta F, Dunn T, Landuyt K, Xu Y, Merino-Torres JF. Flash glucose monitoring reduces glycemic variability and hypoglycemia: real-world data from Spain. BMJ Open Diabetes Res Care 2020;8:e001052. [PMID: 32198165 DOI: 10.1136/bmjdrc-2019-001052] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 17.0] [Reference Citation Analysis]
163 Bale BF, Doneen AL, Vigerust DJ. Precision Healthcare of Type 2 Diabetic Patients Through Implementation of Haptoglobin Genotyping. Front Cardiovasc Med 2018;5:141. [PMID: 30386783 DOI: 10.3389/fcvm.2018.00141] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
164 Almetwazi M, Alwhaibi M, Balkhi B, Almohaini H, Alturki H, Alhawassi T, Ata S, AlQahtani N, Mahmoud M, Alshammari T. Factors associated with glycemic control in type 2 diabetic patients in Saudi Arabia. Saudi Pharm J 2019;27:384-8. [PMID: 30976182 DOI: 10.1016/j.jsps.2018.12.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
165 Timpel P, Oswald S, Schwarz PEH, Harst L. Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses. J Med Internet Res. 2020;22:e16791. [PMID: 32186516 DOI: 10.2196/16791] [Cited by in Crossref: 34] [Cited by in F6Publishing: 26] [Article Influence: 17.0] [Reference Citation Analysis]
166 Araki E, Unno Y, Tanaka Y, Sakamoto W, Miyamoto Y. Long-Term Efficacy and Safety of Linagliptin in a Japanese Population with Type 2 Diabetes Aged ≥ 60 Years Treated with Basal Insulin: A Randomised Trial. Adv Ther 2019;36:2697-711. [PMID: 31482511 DOI: 10.1007/s12325-019-01065-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
167 Turgeon RD, Koshman SL, Youngson E, Pearson GJ. Association Between Hemoglobin A1c and Major Adverse Coronary Events in Patients with Diabetes Following Coronary Artery Bypass Surgery. Pharmacotherapy 2020;40:116-24. [PMID: 31883378 DOI: 10.1002/phar.2359] [Reference Citation Analysis]
168 Perfect MM. Sleep-related disorders in patients with type 1 diabetes mellitus: current insights. Nat Sci Sleep 2020;12:101-23. [PMID: 32104119 DOI: 10.2147/NSS.S152555] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 3.5] [Reference Citation Analysis]
169 Zhao LY, Luo YJ, Zhu J. Letter regarding the article, "A randomized, double- blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients". Drug Des Devel Ther 2019;13:385-6. [PMID: 30718943 DOI: 10.2147/DDDT.S185297] [Reference Citation Analysis]
170 Ganmore I, Beeri MS. The chicken or the egg? Does glycaemic control predict cognitive function or the other way around? Diabetologia. 2018;. [PMID: 30003308 DOI: 10.1007/s00125-018-4689-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
171 Alonso GT, Corathers S, Shah A, Clements M, Kamboj M, Sonabend R, DeSalvo D, Mehta S, Cabrera A, Rioles N, Ohmer A, Mehta R, Lee J. Establishment of the T1D Exchange Quality Improvement Collaborative (T1DX-QI). Clin Diabetes 2020;38:141-51. [PMID: 32327886 DOI: 10.2337/cd19-0032] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
172 Simcoe T, Catillon M, Gertler P. Who benefits most in disease management programs: Improving target efficiency. Health Econ 2019;28:189-203. [PMID: 30345722 DOI: 10.1002/hec.3836] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
173 Premkumar A, Morse K, Levack AE, Bostrom MP, Carli AV. Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis. Curr Rheumatol Rep 2018;20:68. [PMID: 30203376 DOI: 10.1007/s11926-018-0777-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
174 Krishnasamy S, Abell TL. Diabetic Gastroparesis: Principles and Current Trends in Management. Diabetes Ther. 2018;9:1-42. [PMID: 29934758 DOI: 10.1007/s13300-018-0454-9] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
175 Alfadhli EM. Higher rate of hyperglycemia than hypoglycemia during Ramadan fasting in patients with uncontrolled type 1 diabetes: Insight from continuous glucose monitoring system. Saudi Pharm J 2018;26:965-9. [PMID: 30416354 DOI: 10.1016/j.jsps.2018.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
176 Lee DY, Han K, Park S, Yu JH, Seo JA, Kim NH, Yoo HJ, Kim SG, Choi KM, Baik SH, Park YG, Kim NH. Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study. Cardiovasc Diabetol 2020;19:144. [PMID: 32962711 DOI: 10.1186/s12933-020-01134-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
177 Zhu B, Jin S, Wu L, Hu C, Wang Z, Bu L, Sun H, Wang X, Qu S, Chen D. J-shaped association between fasting blood glucose levels and COVID-19 severity in patients without diabetes. Diabetes Res Clin Pract 2020;168:108381. [PMID: 32853687 DOI: 10.1016/j.diabres.2020.108381] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
178 Zhang Y, Li X, Luo S, Liu C, Xie Y, Guo J, Liu F, Zhou Z. Use, Perspectives, and Attitudes Regarding Diabetes Management Mobile Apps Among Diabetes Patients and Diabetologists in China: National Web-Based Survey. JMIR Mhealth Uhealth 2019;7:e12658. [PMID: 30735147 DOI: 10.2196/12658] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 10.3] [Reference Citation Analysis]
179 Khan RN, Saba F, Kausar SF, Siddiqui MH. Pattern of electrolyte imbalance in Type 2 diabetes patients: Experience from a tertiary care hospital. Pak J Med Sci 2019;35:797-801. [PMID: 31258597 DOI: 10.12669/pjms.35.3.844] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
180 Carlson AL, Kanapka LG, Miller KM, Ahmann AJ, Chaytor NS, Fox S, Kiblinger L, Kruger D, Levy CJ, Peters AL, Rickels MR, Salam M, Shah VN, Young LA, Kudva YC, Pratley R; WISDM Study Group. Hypoglycemia and Glycemic Control in Older Adults With Type 1 Diabetes: Baseline Results From the WISDM Study. J Diabetes Sci Technol 2021;15:582-92. [PMID: 31867988 DOI: 10.1177/1932296819894974] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
181 Saisho Y. Use of Diabetes Treatment Satisfaction Questionnaire in Diabetes Care: Importance of Patient-Reported Outcomes. Int J Environ Res Public Health. 2018;15. [PMID: 29747423 DOI: 10.3390/ijerph15050947] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
182 Nebuloni CC, Máximo RO, de Oliveira C, Alexandre TDS. Uncontrolled Diabetes as an Associated Factor with Dynapenia in Adults Aged 50 Years or Older: Sex Differences. J Gerontol A Biol Sci Med Sci 2020;75:1191-7. [PMID: 31665234 DOI: 10.1093/gerona/glz257] [Reference Citation Analysis]
183 Khan RMM, Chua ZJY, Tan JC, Yang Y, Liao Z, Zhao Y. From Pre-Diabetes to Diabetes: Diagnosis, Treatments and Translational Research. Medicina (Kaunas). 2019;55. [PMID: 31470636 DOI: 10.3390/medicina55090546] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 10.3] [Reference Citation Analysis]
184 Helgeson VS, Berg CA, Kelly CS, Van Vleet M, Zajdel M, Tracy EL, Litchman ML. Patient and partner illness appraisals and health among adults with type 1 diabetes. J Behav Med 2019;42:480-92. [PMID: 30542808 DOI: 10.1007/s10865-018-0001-1] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
185 Kuchay MS, Krishan S, Mishra SK, Choudhary NS, Singh MK, Wasir JS, Kaur P, Gill HK, Bano T, Farooqui KJ, Mithal A. Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial). Diabetologia 2020;63:2434-45. [PMID: 32865597 DOI: 10.1007/s00125-020-05265-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 16] [Article Influence: 10.5] [Reference Citation Analysis]
186 Lum E, Jimenez G, Huang Z, Thai L, Semwal M, Boehm BO, Car J. Decision Support and Alerts of Apps for Self-management of Blood Glucose for Type 2 Diabetes. JAMA 2019;321:1530-2. [PMID: 30990543 DOI: 10.1001/jama.2019.1644] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
187 Guo L, Song Y, Li N, Qin B, Hu B, Yi H, Huang J, Liu B, Yu L, Huang Y, Zhou M, Qu J. A New Prognostic Index PDPI for the Risk of Pneumonia Among Patients With Diabetes. Front Cell Infect Microbiol 2021;11:723666. [PMID: 34552886 DOI: 10.3389/fcimb.2021.723666] [Reference Citation Analysis]
188 Pantalone KM, Misra-Hebert AD, Hobbs TM, Kong SX, Ji X, Ganguly R, Milinovich A, Weng W, Bauman JM, Petraro P, Burguera B, Zimmerman RS, Kattan MW. The Probability of A1C Goal Attainment in Patients With Uncontrolled Type 2 Diabetes in a Large Integrated Delivery System: A Prediction Model. Diabetes Care 2020;43:1910-9. [PMID: 32527797 DOI: 10.2337/dc19-0968] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
189 Griffith KN, Prentice JC, Mohr DC, Conlin PR. Predicting 5- and 10-Year Mortality Risk in Older Adults With Diabetes. Diabetes Care 2020;43:1724-31. [PMID: 32669409 DOI: 10.2337/dc19-1870] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
190 Crocker JB, Lynch SH, Guarino AJ, Lewandrowski K. The Impact of Point-of-Care Hemoglobin A1c Testing on Population Health-Based Onsite Testing Adherence: A Primary-Care Quality Improvement Study. J Diabetes Sci Technol 2021;15:561-7. [PMID: 33233954 DOI: 10.1177/1932296820972751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
191 Weinstock RS, Braffett BH, McGuigan P, Larkin ME, Grover NB, Walders-Abramson N, Laffel LM, Chan CL, Chang N, Schwartzman BE, Barajas RA, Celona-Jacobs N, Haymond MW; TODAY Study Group. Self-Monitoring of Blood Glucose in Youth-Onset Type 2 Diabetes: Results From the TODAY Study. Diabetes Care 2019;42:903-9. [PMID: 30833375 DOI: 10.2337/dc18-1854] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
192 Kim G, Lim S, Kwon HS, Park IB, Ahn KJ, Park CY, Kwon SK, Kim HS, Park SW, Kim SG, Moon MK, Kim ES, Chung CH, Park KS, Kim M, Chung DJ, Lee CB, Kim TH, Lee MK. Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active-controlled, randomized, double-blind study with open-label extension (the EVERGREEN study). Diabetes Obes Metab 2020;22:1527-36. [PMID: 32319168 DOI: 10.1111/dom.14061] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
193 Xu L, Zhang P, Huang Z, Zhong L, Li H, Liu L, Liu J, Xiao H, Li Y. Hypoglycemia during Short-Term Intensive Insulin Therapy and Its Association with Long-Term Glycemic Remission in Patients with Newly Diagnosed Type 2 Diabetes. J Diabetes Res 2020;2020:4097469. [PMID: 32149152 DOI: 10.1155/2020/4097469] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
194 Noueiri B, Nassif N. Dental Treatment Effect on Blood Glucose Level Fluctuation in Type 1 Unbalanced Diabetic Children. Int J Clin Pediatr Dent 2021;14:497-501. [PMID: 34824503 DOI: 10.5005/jp-journals-10005-1985] [Reference Citation Analysis]
195 Cho YK, Lee J, Kang YM, Yoo JH, Park JY, Jung CH, Lee WJ. Clinical parameters affecting the therapeutic efficacy of empagliflozin in patients with type 2 diabetes. PLoS One 2019;14:e0220667. [PMID: 31369642 DOI: 10.1371/journal.pone.0220667] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
196 Tefera YG, Gebresillassie BM, Emiru YK, Yilma R, Hafiz F, Akalu H, Ayele AA. Diabetic health literacy and its association with glycemic control among adult patients with type 2 diabetes mellitus attending the outpatient clinic of a university hospital in Ethiopia. PLoS One 2020;15:e0231291. [PMID: 32267893 DOI: 10.1371/journal.pone.0231291] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
197 Mizuno M, Iizuka K, Ishihara T, Fukaya S, Yoshida S, Takeda J. High Dose Prednisolone Lowers Plasma Glycated Albumin Levels Compared to Actual Glycemic Control: A Retrospective Observational Study. Diabetes Ther 2019;10:269-76. [PMID: 30547387 DOI: 10.1007/s13300-018-0552-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
198 McCoy RG, Lipska KJ, Van Houten HK, Shah ND. Association of Cumulative Multimorbidity, Glycemic Control, and Medication Use With Hypoglycemia-Related Emergency Department Visits and Hospitalizations Among Adults With Diabetes. JAMA Netw Open 2020;3:e1919099. [PMID: 31922562 DOI: 10.1001/jamanetworkopen.2019.19099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
199 Lorenzo O, Crespo-Yanguas M, Hang T, Lumpuy-Castillo J, Hernández AM, Llavero C, García-Alonso M, Ruiz-Tovar J. Addition of Probiotics to Anti-Obesity Therapy by Percutaneous Electrical Stimulation of Dermatome T6. A Pilot Study. Int J Environ Res Public Health 2020;17:E7239. [PMID: 33023060 DOI: 10.3390/ijerph17197239] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
200 Smith ML, Zhong L, Lee S, Towne SD Jr, Ory MG. Effectiveness and economic impact of a diabetes education program among adults with type 2 diabetes in South Texas. BMC Public Health 2021;21:1646. [PMID: 34503468 DOI: 10.1186/s12889-021-11632-9] [Reference Citation Analysis]
201 Naqvi JB, Helgeson VS, Gary-Webb TL, Korytkowski MT, Seltman HJ. Sex, race, and the role of relationships in diabetes health: intersectionality matters. J Behav Med 2020;43:69-79. [PMID: 31102104 DOI: 10.1007/s10865-019-00057-w] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
202 Solomon TPJ, Tarry E, Hudson CO, Fitt AI, Laye MJ. Immediate post-breakfast physical activity improves interstitial postprandial glycemia: a comparison of different activity-meal timings. Pflugers Arch 2020;472:271-80. [PMID: 31396757 DOI: 10.1007/s00424-019-02300-4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
203 Hasan SMM, Rahman M, Nakamura K, Tashiro Y, Miyashita A, Seino K. Relationship between diabetes self-care practices and control of periodontal disease among type2 diabetes patients in Bangladesh. PLoS One 2021;16:e0249011. [PMID: 33822810 DOI: 10.1371/journal.pone.0249011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
204 Todo H. Continuous glucose monitoring can disclose glucose fluctuation in advanced Parkinsonian syndromes. Neurol Int 2018;10:7921. [PMID: 30687470 DOI: 10.4081/ni.2018.7921] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
205 Thever Y, Teo BJX, Tan HCA. Predictive value of common serum glycaemic markers on periprosthetic joint infection following Total Joint Arthroplasty: A review of the literature. J Orthop 2020;22:278-81. [PMID: 32581459 DOI: 10.1016/j.jor.2020.06.006] [Reference Citation Analysis]
206 Rouf S, Ezzerrouqi A, Benyakhlef S, Abda N, Latrech H. Flexible insulin therapy improves metabolic control and decreases the risk of hypoglycemia in type 1 diabetic patients. Pan Afr Med J 2021;40:100. [PMID: 34909088 DOI: 10.11604/pamj.2021.40.100.18097] [Reference Citation Analysis]
207 Fattah H, Vallon V. The Potential Role of SGLT2 Inhibitors in the Treatment of Type 1 Diabetes Mellitus. Drugs. 2018;78:717-726. [PMID: 29663292 DOI: 10.1007/s40265-018-0901-y] [Cited by in Crossref: 35] [Cited by in F6Publishing: 23] [Article Influence: 11.7] [Reference Citation Analysis]
208 Nam GE, Han B, Joo CL, Kang SY, Lim J, Kim YH, Park HS. Poor Control of Blood Glucose, Lifestyle, and Cardiometabolic Parameters in Younger Adult Patients with Type 2 Diabetes Mellitus. J Clin Med 2019;8:E1405. [PMID: 31500193 DOI: 10.3390/jcm8091405] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
209 Gebrie D, Getnet D, Manyazewal T. Cardiovascular safety and efficacy of metformin-SGLT2i versus metformin-sulfonylureas in type 2 diabetes: systematic review and meta-analysis of randomized controlled trials. Sci Rep 2021;11:137. [PMID: 33420333 DOI: 10.1038/s41598-020-80603-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
210 Pineda O, Stepenka V, Rivas-motenegro A, Villasmil-hernandez N, Añez R, Salazar J. Sarcopenia in patients with type 2 diabetes mellitus: a case–control study in Maracaibo city, Venezuela. Int J Diabetes Dev Ctries. [DOI: 10.1007/s13410-021-00989-7] [Reference Citation Analysis]
211 Yoo H, Choo E, Lee S. Study of hospitalization and mortality in Korean diabetic patients using the diabetes complications severity index. BMC Endocr Disord 2020;20:122. [PMID: 32778100 DOI: 10.1186/s12902-020-00605-5] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Zhou Y, Deng H, Liu H, Yang D, Xu W, Yao B, Yan J, Weng J. Effects of novel flash glucose monitoring system on glycaemic control in adult patients with type 1 diabetes mellitus: protocol of a multicentre randomised controlled trial. BMJ Open 2020;10:e039400. [PMID: 33277281 DOI: 10.1136/bmjopen-2020-039400] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
213 Moon JY, Louie TL, Jain D, Sofer T, Schurmann C, Below JE, Lai CQ, Aviles-Santa ML, Talavera GA, Smith CE, Petty LE, Bottinger EP, Chen YI, Taylor KD, Daviglus ML, Cai J, Wang T, Tucker KL, Ordovás JM, Hanis CL, Loos RJF, Schneiderman N, Rotter JI, Kaplan RC, Qi Q. A Genome-Wide Association Study Identifies Blood Disorder-Related Variants Influencing Hemoglobin A1c With Implications for Glycemic Status in U.S. Hispanics/Latinos. Diabetes Care 2019;42:1784-91. [PMID: 31213470 DOI: 10.2337/dc19-0168] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
214 Davies MJ, D'Alessio DA, Fradkin J, Kernan WN, Mathieu C, Mingrone G, Rossing P, Tsapas A, Wexler DJ, Buse JB. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2018;41:2669-2701. [PMID: 30291106 DOI: 10.2337/dci18-0033] [Cited by in Crossref: 1065] [Cited by in F6Publishing: 871] [Article Influence: 266.3] [Reference Citation Analysis]
215 Wang T, Lu J, Su Q, Chen Y, Bi Y, Mu Y, Chen L, Hu R, Tang X, Yu X, Li M, Xu M, Xu Y, Zhao Z, Yan L, Qin G, Wan Q, Chen G, Dai M, Zhang D, Gao Z, Wang G, Shen F, Luo Z, Qin Y, Chen L, Huo Y, Li Q, Ye Z, Zhang Y, Liu C, Wang Y, Wu S, Yang T, Deng H, Li D, Lai S, Bloomgarden ZT, Shi L, Ning G, Zhao J, Wang W; 4C Study Group. Ideal Cardiovascular Health Metrics and Major Cardiovascular Events in Patients With Prediabetes and Diabetes. JAMA Cardiol 2019;4:874-83. [PMID: 31365039 DOI: 10.1001/jamacardio.2019.2499] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 8.5] [Reference Citation Analysis]
216 Blonde L, Meneghini L, Peng XV, Boss A, Rhee K, Shaunik A, Kumar S, Balodi S, Brulle-Wohlhueter C, McCrimmon RJ. Probability of Achieving Glycemic Control with Basal Insulin in Patients with Type 2 Diabetes in Real-World Practice in the USA. Diabetes Ther 2018;9:1347-58. [PMID: 29600507 DOI: 10.1007/s13300-018-0413-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
217 Zuo X, Liu X, Chen R, Ou H, Lai J, Zhang Y, Yan D. An in-depth analysis of glycosylated haemoglobin level, body mass index and left ventricular diastolic dysfunction in patients with type 2 diabetes. BMC Endocr Disord 2019;19:88. [PMID: 31455303 DOI: 10.1186/s12902-019-0419-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
218 Alexopoulos AS, Jackson GL, Edelman D, Smith VA, Berkowitz TSZ, Woolson SL, Bosworth HB, Crowley MJ. Clinical factors associated with persistently poor diabetes control in the Veterans Health Administration: A nationwide cohort study. PLoS One 2019;14:e0214679. [PMID: 30925177 DOI: 10.1371/journal.pone.0214679] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
219 Mané DI, Demba D, Djiby S, Assane NM, Limane BA, Marie KC, Anna S, Maimouna NM. [Clinical and progressive profile of skin and soft tissue lesions in diabetics in 2017 at the dressing room of the Marc Sankale Center in Dakar]. Pan Afr Med J 2019;32:209. [PMID: 31312321 DOI: 10.11604/pamj.2019.32.209.18524] [Reference Citation Analysis]
220 Timpel P, Harst L. Research Implications for Future Telemedicine Studies and Innovations in Diabetes and Hypertension-A Mixed Methods Study. Nutrients 2020;12:E1340. [PMID: 32397096 DOI: 10.3390/nu12051340] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
221 Christensen MMB, Hommel EE, Jørgensen ME, Fleischer J, Hansen CS. Glycemic Variability and Diabetic Neuropathy in Young Adults With Type 1 Diabetes. Front Endocrinol (Lausanne) 2020;11:644. [PMID: 33071962 DOI: 10.3389/fendo.2020.00644] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
222 Nayeem J, Chowdhury HA, Afroze N, Mili US, Ali L. Proportion and predictors of SMBG use among type 2 diabetic subjects in three tertiary care hospitals in Dhaka City. Heliyon 2021;7:e07619. [PMID: 34355103 DOI: 10.1016/j.heliyon.2021.e07619] [Reference Citation Analysis]
223 Glaess SS, Benitez RM, Cross BM, Urteaga EM. Acute Hyperglycemia After Influenza Vaccination in a Patient With Type 2 Diabetes. Diabetes Spectr 2018;31:206-8. [PMID: 29773944 DOI: 10.2337/ds16-0068] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
224 Honick K. Does Nutrition Counseling Affect Glycosylated Hemoglobin and Estimated Glomerular Filtration Rate in Patients With Diabetes and Stage 3 Chronic Kidney Disease? The Journal for Nurse Practitioners 2020;16:695-8. [DOI: 10.1016/j.nurpra.2020.05.010] [Reference Citation Analysis]
225 Braune K, O'Donnell S, Cleal B, Lewis D, Tappe A, Willaing I, Hauck B, Raile K. Real-World Use of Do-It-Yourself Artificial Pancreas Systems in Children and Adolescents With Type 1 Diabetes: Online Survey and Analysis of Self-Reported Clinical Outcomes. JMIR Mhealth Uhealth 2019;7:e14087. [PMID: 31364599 DOI: 10.2196/14087] [Cited by in Crossref: 40] [Cited by in F6Publishing: 28] [Article Influence: 13.3] [Reference Citation Analysis]
226 Martin CT, Criego AB, Carlson AL, Bergenstal RM. Advanced Technology in the Management of Diabetes: Which Comes First-Continuous Glucose Monitor or Insulin Pump? Curr Diab Rep 2019;19:50. [PMID: 31250124 DOI: 10.1007/s11892-019-1177-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
227 Drincic AT. Analysis of "Use of Blood Glucose Meters Featuring Color Range Indicators Improves Glycemic Control and Patients With Diabetes in Comparison to Blood Glucose Meters Without Color (ACCENTS Study)". J Diabetes Sci Technol 2018;12:1220-2. [PMID: 30095006 DOI: 10.1177/1932296818793115] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
228 Saydah S, Imperatore G, Divers J, Bell R, Henkin L, Mayer-Davis E, Zhong VW, Dabelea D, Lawrence JM, Pihoker C. Occurrence of severe hypoglycaemic events among US youth and young adults with type 1 or type 2 diabetes. Endocrinol Diabetes Metab 2019;2:e00057. [PMID: 31008365 DOI: 10.1002/edm2.57] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
229 Wahabi H, Fayed A, Tunkar SMS, Bakhsh H, Al-Hazmi AM, Esmaeil S, Siddiqui AR. Incidence and contributing factors of glucose intolerance in Saudi postpartum women: Sub-group analysis from RAHMA study. PLoS One 2019;14:e0210024. [PMID: 30615670 DOI: 10.1371/journal.pone.0210024] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
230 Krhač M, Lovrenčić MV. Update on biomarkers of glycemic control. World J Diabetes 2019; 10(1): 1-15 [PMID: 30697366 DOI: 10.4239/wjd.v10.i1.1] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 21] [Article Influence: 9.7] [Reference Citation Analysis]
231 Twigg SM, Escalada J, Stella P, Merino-Trigo A, Lavalle-Gonzalez FJ, Cariou B, Meneghini LF. Association of Patient Profile with Glycemic Control and Hypoglycemia with Insulin Glargine 300 U/mL in Type 2 Diabetes: A Post Hoc Patient-Level Meta-Analysis. Diabetes Ther 2018;9:2043-53. [PMID: 30203238 DOI: 10.1007/s13300-018-0498-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
232 Ng KKK, Cheung CYY, Lee CH, Fong CHY, Kwok KHM, Li KKW, Gangwani RA, Wong IYH, Woo YC, Chow WS, Yuen MMA, Wong RLC, Xu A, Wong DSH, Sham PC, Lam KSL. Possible Modifying Effect of Hemoglobin A1c on Genetic Susceptibility to Severe Diabetic Retinopathy in Patients With Type 2 Diabetes. Invest Ophthalmol Vis Sci 2020;61:7. [PMID: 32756921 DOI: 10.1167/iovs.61.10.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
233 Wan KS, Moy FM, Mohd Yusof K, Mustapha FI, Mohd Ali Z, Hairi NN. Clinical inertia in type 2 diabetes management in a middle-income country: A retrospective cohort study. PLoS One 2020;15:e0240531. [PMID: 33035261 DOI: 10.1371/journal.pone.0240531] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
234 Chetoui A, Kaoutar K, Boutahar K, El Kardoudi A, Elmoussaoui S, Chigr F, Najimi M. Prevalence of overweight/obesity and its associated factors among a sample of Moroccan type 2 diabetes patients. Afr Health Sci 2021;21:23-31. [PMID: 34394277 DOI: 10.4314/ahs.v21i1.5] [Reference Citation Analysis]
235 Ebid AIM, Ehab M, Ismail A, Soror S, Mahmoud MA. The influence of SLC22A1 rs622342 and ABCC8 rs757110 genetic variants on the efficacy of metformin and glimepiride combination therapy in Egyptian patients with type 2 diabetes. J Drug Assess 2019;8:115-21. [PMID: 31231590 DOI: 10.1080/21556660.2019.1619571] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
236 Hussain S, Chowdhury TA. The Impact of Comorbidities on the Pharmacological Management of Type 2 Diabetes Mellitus. Drugs 2019;79:231-42. [PMID: 30742277 DOI: 10.1007/s40265-019-1061-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
237 Yuan L, Li F, Zhou Y, Sun R, Gao G, Zhang Q, Tang Y, Dai L, Wu J, Ma J. Fasting Glucose of 6.1 mmol/L as a Possible Optimal Target for Type 2 Diabetic Patients with Insulin Glargine: A Randomized Clinical Trial. J Diabetes Res 2021;2021:5524313. [PMID: 34337072 DOI: 10.1155/2021/5524313] [Reference Citation Analysis]
238 Deiss D, Szadkowska A, Gordon D, Mallipedhi A, Schütz-Fuhrmann I, Aguilera E, Ringsell C, De Block C, Irace C. Clinical Practice Recommendations on the Routine Use of Eversense, the First Long-Term Implantable Continuous Glucose Monitoring System. Diabetes Technol Ther 2019;21:254-64. [PMID: 31021180 DOI: 10.1089/dia.2018.0397] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
239 Babic N, Valjevac A, Zaciragic A, Avdagic N, Zukic S, Hasic S. The Triglyceride/HDL Ratio and Triglyceride Glucose Index as Predictors of Glycemic Control in Patients with Diabetes Mellitus Type 2. Med Arch 2019;73:163-8. [PMID: 31404127 DOI: 10.5455/medarh.2019.73.163-168] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
240 Vázquez-de Sebastián J, Ciudin A, Castellano-Tejedor C. Analysis of Effectiveness and Psychological Techniques Implemented in mHealth Solutions for Middle-Aged and Elderly Adults with Type 2 Diabetes: A Narrative Review of the Literature. J Clin Med 2021;10:2701. [PMID: 34207402 DOI: 10.3390/jcm10122701] [Reference Citation Analysis]
241 Lingvay I, Buse JB, Franek E, Hansen MV, Koefoed MM, Mathieu C, Pettus J, Stachlewska K, Rosenstock J. A Randomized, Open-Label Comparison of Once-Weekly Insulin Icodec Titration Strategies Versus Once-Daily Insulin Glargine U100. Diabetes Care 2021:dc202878. [PMID: 33875484 DOI: 10.2337/dc20-2878] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
242 Hall M, Walicka M, Panczyk M, Traczyk I. Assessing Long-Term Impact of Dietary Interventions on Occurrence of Symptoms Consistent with Hypoglycemia in Patients without Diabetes: A One-Year Follow-Up Study. Nutrients 2022;14:497. [DOI: 10.3390/nu14030497] [Reference Citation Analysis]
243 Meldgaard T, Olesen SS, Farmer AD, Krogh K, Wendel AA, Brock B, Drewes AM, Brock C. Diabetic Enteropathy: From Molecule to Mechanism-Based Treatment. J Diabetes Res. 2018;2018:3827301. [PMID: 30306092 DOI: 10.1155/2018/3827301] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 3.5] [Reference Citation Analysis]
244 Gill M, Chhabra H, Shah M, Zhu C, Lando H, Caldarella F. Association between provider specialty and healthcare costs and glycemic control for patients with diabetes. J Med Econ 2018;21:704-8. [PMID: 29669452 DOI: 10.1080/13696998.2018.1467324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
245 Shiyanbola OO, Walbrandt Pigarelli DL, Unni EJ, Smith PD, Maurer MA, Huang YM. Design and rationale of a mixed methods randomized control trial: ADdressing Health literacy, bEliefs, adheRence and self-Efficacy (ADHERE) program to improve diabetes outcomes. Contemp Clin Trials Commun 2019;14:100326. [PMID: 30705995 DOI: 10.1016/j.conctc.2019.100326] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
246 Niroomand M, Babaniamansour S, Aliniagerdroudbari E, Golshaian A, Meibodi AM, Absalan A. Distress and depression among patients with diabetes mellitus: prevalence and associated factors: a cross-sectional study. J Diabetes Metab Disord 2021;20:141-51. [PMID: 34178826 DOI: 10.1007/s40200-020-00721-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
247 Gallardo-Rincón H, Montoya A, Saucedo-Martínez R, Mújica-Rosales R, Suárez-Idueta L, Martínez-Juárez LA, Razo C, Lozano R, Tapia-Conyer R. Integrated Measurement for Early Detection (MIDO) as a digital strategy for timely assessment of non-communicable disease profiles and factors associated with unawareness and control: a retrospective observational study in primary healthcare facilities in Mexico. BMJ Open 2021;11:e049836. [PMID: 34475175 DOI: 10.1136/bmjopen-2021-049836] [Reference Citation Analysis]
248 Alamoudi R, Alsubaiee M, Alqarni A, Aljaser S, Saleh Y, Salam A, Eledrisi M. Attitudes and habits of patients with type 1 diabetes during fasting Ramadan. J Clin Transl Endocrinol 2018;14:1-4. [PMID: 30294552 DOI: 10.1016/j.jcte.2018.09.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
249 Gebrie D, Manyazewal T, A Ejigu D, Makonnen E. Metformin-Insulin versus Metformin-Sulfonylurea Combination Therapies in Type 2 Diabetes: A Comparative Study of Glycemic Control and Risk of Cardiovascular Diseases in Addis Ababa, Ethiopia. Diabetes Metab Syndr Obes 2021;14:3345-59. [PMID: 34335036 DOI: 10.2147/DMSO.S312997] [Reference Citation Analysis]